J 2023

Cerebrospinal fluid neurofilament light chains and CXCL13 as predictive factors for clinical course of multiple sclerosis

HRADILEK, Pavel, Kamila Zondra REVENDOVA ZONDRA, Jana HORAKOVA, Radovan BUNGANIC, Ondřej PELÍŠEK et. al.

Basic information

Original name

Cerebrospinal fluid neurofilament light chains and CXCL13 as predictive factors for clinical course of multiple sclerosis

Authors

HRADILEK, Pavel (203 Czech Republic, guarantor), Kamila Zondra REVENDOVA ZONDRA (203 Czech Republic), Jana HORAKOVA (203 Czech Republic), Radovan BUNGANIC (203 Czech Republic), Ondřej PELÍŠEK (203 Czech Republic, belonging to the institution), David ZEMAN (203 Czech Republic), Pavla HANZLIKOVA (203 Czech Republic) and Pavlina KUSNIEROVA (203 Czech Republic)

Edition

Biomedical Papers, Olomouc: Palacky University, Olomouc, Palacky University, 2023, 1213-8118

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30210 Clinical neurology

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 0.900 in 2022

RIV identification code

RIV/00216224:14110/23:00130656

Organization unit

Faculty of Medicine

UT WoS

000922647200001

Keywords in English

multiple sclerosis; biomarkers; neurofilament light chain; CXCL13; clinical course

Tags

Tags

International impact, Reviewed
Změněno: 30/1/2024 08:12, Mgr. Tereza Miškechová

Abstract

V originále

Aim. The aim of this study was to identify whether NfL and CXCL13 cerebrospinal fluid (CSF) concentrations at diagnos-tic lumbar puncture can predict the course of multiple sclerosis (MS) in terms of relapses, higher expanded disability status scale (EDSS) and magnetic resonance imaging (MRI) activity.Methods. We conducted a single-centre prospective observational cohort study at the MS center, University Hospital Ostrava, Czech Republic. CSF NfL (cNfL) and CXCL13 concentrations were examined (ELISA method) in patients with clinically isolated syndrome (CIS) and relapsing-remitting MS (RRMS) at the time of diagnostic lumbar puncture.Results. A total of 44 patients with CIS or early RRMS were enrolled, 31 (70.5%) of whom were women. The median age at the time of CSF sampling was 31.21 years (IQR 25.43-39.32), and the follow-up period was 54.6 months (IQR 44.03 - 59.48). In the simple and multiple logistic regression models, CXCL13 levels did not predict relapses, MRI activ-ity or EDSS > 2.5. Similarly, cNfL concentrations did not predict relapses or MRI activity in either model. In the multiple regression, higher cNfL levels were associated with reaching EDSS > 2.5 (odds ratio [OR] 1.002, 95% confidence interval [CI] 1.000 to 1.003).Conclusions. Our data did not confirm cNfL and/or CXCL13 CSF levels were predictive factors for disease activity such as relapses and MRI activity at the time of diagnostic lumbar puncture in patients with RRMS. While cNfL CSF levels predicted higher disability only after adjustment for other known risk factors, elevated CSF CXCL13 did not predict higher disability at all.